Zurcher Kantonalbank Zurich Cantonalbank Has $5.49 Million Stake in Astera Labs, Inc. $ALAB

Key Points

• Zurcher Kantonalbank increased its stake in Astera Labs by 27.6% in Q4 to 32,975 shares valued at about $5.49 million, contributing to institutional ownership of roughly 60.5%.
• Operational momentum: Astera Labs beat Q4 estimates (EPS $0.58 vs. $0.51) with revenue of $270.6M (+91.8% YoY), guided Q1 EPS of $0.530–$0.540, and enjoys broadly bullish analyst coverage (average target ≈ $199.74).
• Significant insider selling is a near‑term risk — insiders, including executives and directors, sold about 1,064,888 shares worth roughly $150.8 million in the past 90 days, which may weigh on sentiment despite strong growth.

Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 27.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 32,975 shares of the company's stock after buying an additional 7,142 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Astera Labs were worth $5,486,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Vanguard Group Inc. grew its position in Astera Labs by 14.1% in the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock valued at $2,690,907,000 after purchasing an additional 1,693,918 shares during the period. State Street Corp raised its holdings in Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company's stock worth $458,065,000 after buying an additional 195,992 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in shares of Astera Labs by 46.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company's stock valued at $295,203,000 after buying an additional 479,360 shares in the last quarter. Amundi lifted its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company's stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Finally, Value Aligned Research Advisors LLC lifted its stake in shares of Astera Labs by 16.7% in the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company's stock valued at $269,881,000 after buying an additional 197,320 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Wall Street and institutions backing the story — multiple buy/outperform ratings and a cluster of price targets (median ~$215) plus large Q4 2025 institutional purchases (e.g., BlackRock) support bullish positioning and provide demand for the stock. Astera Labs gains as investors refocus on AI interconnect demand and upcoming earnings catalyst
• Positive Sentiment: AI-infrastructure narrative and upcoming earnings act as a near-term catalyst — investors are repositioning ahead of early‑May Q1 results and continue to value Astera’s role in solving data‑center connectivity bottlenecks (Aries/Scorpio product relevance). Cramer Names 'The Stocks That Got Away'
• Positive Sentiment: Favorable industry coverage highlights the company’s strategic positioning in AI data centers, reinforcing growth expectations. This thematic coverage can drive momentum among growth and thematic funds. Astera Labs: The Tollbooth for AI's Traffic Jam
• Neutral Sentiment: UBS initiated coverage with a Neutral rating — this provides liquidity and analyst visibility but is not an explicit endorsement; UBS’s target (~$180) is below the median of recent targets, which may cap upside for some investors. Astera Labs NASDAQ: ALAB Research Coverage Started at UBS Group
• Neutral Sentiment: Coverage pieces highlighting insider ownership and growth metrics signal interest from investors who track insider alignment, but these lists are informational rather than direct catalysts. April 2026's High Insider Ownership Growth Leaders
• Negative Sentiment: Significant insider selling — CEO Jitendra Mohan and other senior insiders have sold large blocks in April under 10b5-1 plans (reports show tens of millions in proceeds). Heavy insider liquidation can pressure sentiment and raise short‑term selling risk despite the company’s growth story. This AI Stock Has Tripled Since Its IPO. Its CEO Just Cashed In. Insider Selling: Astera Labs NASDAQ: ALAB CEO Sells $56,064,793.02 in Stock

Astera Labs Price Performance

NASDAQ ALAB opened at $212.84 on Friday. Astera Labs, Inc. has a 1 year low of $62.31 and a 1 year high of $262.90. The firm has a market cap of $36.45 billion, a price-to-earnings ratio of 174.46, a PEG ratio of 3.89 and a beta of 1.78. The company has a fifty day moving average price of $133.87 and a 200-day moving average price of $154.02.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same quarter in the prior year, the business posted $0.37 EPS. The business's revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ALAB. Royal Bank Of Canada reiterated an "outperform" rating and set a $250.00 price objective on shares of Astera Labs in a report on Tuesday. Barclays set a $165.00 price objective on shares of Astera Labs in a report on Thursday, January 15th. Loop Capital began coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a "buy" rating and a $250.00 price objective for the company. Weiss Ratings cut shares of Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, February 23rd. Finally, Citigroup began coverage on shares of Astera Labs in a report on Thursday, April 2nd. They set a "buy" rating and a $200.00 price objective for the company. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $199.74.

Insider Activity

In other news, Director Manuel Alba sold 183,000 shares of the company's stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of the company's stock in a transaction on Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the completion of the sale, the director owned 67,144 shares of the company's stock, valued at approximately $11,758,257.28. The trade was a 5.30% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,064,888 shares of company stock worth $150,764,723. 12.50% of the stock is owned by insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.